INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,430 Cr | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr |
What is the latest Total Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,430 Cr |
| Mar2024 | ₹2,178 Cr |
| Mar2023 | ₹1,714 Cr |
| Mar2022 | ₹1,579 Cr |
| Mar2021 | ₹1,334 Cr |
How is Total Liabilities of INDOCO REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,430 Cr | 11.59 | |
| Mar2024 | ₹2,178 Cr | 27.03 | |
| Mar2023 | ₹1,714 Cr | 8.55 | |
| Mar2022 | ₹1,579 Cr | 18.37 | |
| Mar2021 | ₹1,334 Cr | - | |
Compare Total Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,953.5 Cr | -1.4% | 14.4% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.4% |
14.4% |
-12.8% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses